Phialogics is a preclinical biotech company specialized in engineering next-generation biologics to rebalance the immune response in acute and chronic inflammation.
Products, services, technology
Phialogics concept is based on the targeted modification of immunoglobulin receptor domains (IgVs) to modulate immune response in inflammatory diseases. Phialogics lead molecules replicate endogenous protein-protein interactions to efficiently modulate the function of their target receptor.
- http://www.phialogics.com
- +33 766 57 40 30
- Send an email
- Pascal Oromi
Some insights
We, at Phialogics, are dedicated to improve the life of patients suffering from autoimmune disease. And, from the first day, this is our day-to-day motivation !